MICU1 and ovarian carcinoma: Chakraborty and colleagues [32] recently demonstrated that MICU1 overexpression in ovarian cancer cells induces both glycolysis and chemoresistance and that MICU1 overexpression in patients with ovarian cancer correlates with poor overall survival.